Authum Investment & Infrastructure Limited (AIIL) has made a strategic move in the healthcare sector by entering into a Share Subscription cum Purchase Agreement (SSPA) with Rivaara Labs Private Limited. The deal, valued at Rs 36.57 crore, will see Authum acquiring a 35.09% stake in Rivaara Labs, a company specializing in diagnostic services.

Transaction Details

The transaction involves two key components:

1. Primary Infusion: Authum will subscribe to 3.6 crore cumulative compulsorily convertible participating preference shares (CCPS) of Rivaara Labs for Rs 36.00 crore.
2. Share Purchase: Authum will acquire existing shares from current shareholders for Rs 0.57 crore. This includes:
   • 1.58 crore equity shares
   • 4.10 crore CCPS

Upon completion, Authum will hold a total of 7.70 crore CCPS and 1.58 crore equity shares, granting it 35.09% of the total voting rights in Rivaara Labs.

About Rivaara Labs

Rivaara Labs Private Limited, incorporated on October 18, 2019, operates in the diagnostic services sector. Its business activities include:

• Establishing and operating diagnostic service centers for pathology, imaging, PCR testing, and genomic sequencing
• Distribution, marketing, and manufacturing of point-of-care diagnostic kits and equipment based on molecular biology in India
• Providing RT-PCR related diagnostic services
• Offering digital healthcare products and services related to diagnostics

Financial Overview

As of March 31, 2025, Rivaara Labs reported:

• Net Worth: Rs (3,482.93) lakh (negative)
• Turnover: Rs 2,552.69 lakh

The company's turnover for the past three fiscal years:

Strategic Implications

This acquisition aligns with Authum Investment & Infrastructure's long-term strategy of diversifying its portfolio while investing in sectors with stability and growth potential. The company aims to nurture and expand this business, focusing on value creation for all stakeholders and ensuring a sustainable, profitable future.

Transaction Timeline

The acquisition is expected to be completed by September 30, 2025, subject to the fulfillment of conditions precedent, including board and shareholder approvals of Rivaara Labs.

Regulatory Compliance

The transaction does not fall under related party transactions, and no governmental or regulatory approvals are anticipated to be required for the acquisition.

Authum Investment & Infrastructure Limited has disclosed this information in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, demonstrating transparency in its corporate actions.

As the healthcare and diagnostics sector continues to evolve, this strategic investment by Authum in Rivaara Labs could potentially strengthen its position in the growing Indian healthcare market.

Authum Investment and Infrastructure Limited has seen a significant increase in the stake held by Mentor Capital Limited and Alpana Dangi, strengthening their position as major shareholders. The transaction, which took place on August 14, 2025, involved the acquisition of an additional 46,61,309 shares through open market purchases.

Stake Increase Details

The combined shareholding of Mentor Capital and Alpana Dangi in Authum Investment has risen from 71.54% to 74.28% of the company's total voting rights, representing an increase of 2.74%.

Shareholding Breakdown

Before the transaction:

After the acquisition:

Transaction Specifics

• Date of acquisition: August 14, 2025
• Mode of acquisition: Open market purchase
• Cost of acquisition: 2.74% of the total voting capital

Company Information

Authum Investment's equity share capital remains unchanged at Rs. 16,98,45,100, divided into 169,845,100 shares of Re. 1 each. The company's shares are listed on both the BSE Limited and the National Stock Exchange of India Limited.

Regulatory Compliance

This acquisition has been reported in compliance with Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The disclosure, dated August 16, 2025, provides transparency regarding the change in shareholding structure of the company.

The move by Mentor Capital and Alpana Dangi to increase their stake in Authum Investment reflects a strategic decision to strengthen their position in the company. As major shareholders, their actions will likely be closely watched by other investors and market analysts.